DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity

Alexander Muik, Homer C Adams, Friederike Gieseke, Isil Altintas, Kristina B Schoedel, Jordan M Blum, Bianca Sänger, Saskia M Burm, Eliana Stanganello, Dennis Verzijl, Vanessa M Spires, Fulvia Vascotto, Aras Toker, Juliane Quinkhardt, Mark Fereshteh, Mustafa Diken, David P E Satijn, Sebastian Kreiter, Tahamtan Ahmadi, Esther C W Breij, Özlem Türeci, Kate Sasser, Ugur Sahin, Maria Jure-Kunkel

Open source

DOI
10.1136/jitc-2021-004322
Published
2022-06
Container
Journal for ImmunoTherapy of Cancer
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2021-004322,
  title = {DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity},
  author = {Alexander Muik and Homer C Adams and Friederike Gieseke and Isil Altintas and Kristina B Schoedel and Jordan M Blum and Bianca Sänger and Saskia M Burm and Eliana Stanganello and Dennis Verzijl and Vanessa M Spires and Fulvia Vascotto and Aras Toker and Juliane Quinkhardt and Mark Fereshteh and Mustafa Diken and David P E Satijn and Sebastian Kreiter and Tahamtan Ahmadi and Esther C W Breij and Özlem Türeci and Kate Sasser and Ugur Sahin and Maria Jure-Kunkel},
  year = {2022},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1136/jitc-2021-004322},
  url = {https://doi.org/10.1136/jitc-2021-004322}
}

RIS

TY  - JOUR
TI  - DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity
AU  - Alexander Muik
AU  - Homer C Adams
AU  - Friederike Gieseke
AU  - Isil Altintas
AU  - Kristina B Schoedel
AU  - Jordan M Blum
AU  - Bianca Sänger
AU  - Saskia M Burm
AU  - Eliana Stanganello
AU  - Dennis Verzijl
AU  - Vanessa M Spires
AU  - Fulvia Vascotto
AU  - Aras Toker
AU  - Juliane Quinkhardt
AU  - Mark Fereshteh
AU  - Mustafa Diken
AU  - David P E Satijn
AU  - Sebastian Kreiter
AU  - Tahamtan Ahmadi
AU  - Esther C W Breij
AU  - Özlem Türeci
AU  - Kate Sasser
AU  - Ugur Sahin
AU  - Maria Jure-Kunkel
PY  - 2022
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2021-004322
UR  - https://doi.org/10.1136/jitc-2021-004322
ER  - 

APA

Muik, A., Adams, H. C., Gieseke, F., Altintas, I., Schoedel, K. B., Blum, J. M., Sänger, B., Burm, S. M., Stanganello, E., Verzijl, D., Spires, V. M., Vascotto, F., Toker, A., Quinkhardt, J., Fereshteh, M., Diken, M., Satijn, D. P. E., Kreiter, S., Ahmadi, T., Breij, E. C. W., Türeci, Ö., Sasser, K., Sahin, U., & Jure-Kunkel, M. (2022). DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2021-004322

Source records